Dr. Cem Söllü is a Senior Strategic Healthcare Partner specializing in amyloidosis, currently working at a prominent healthcare organization. They have held various positions in the healthcare field, including roles at IFFMEDIC, Ethypharm, and Pfizer, where they focused on diagnostics and rare diseases. Dr. Söllü completed their doctoral studies in genetic therapy at Charité - Universitätsmedizin Berlin and has furthered their education with a Negotiation Master Class from the University of St. Thomas. Previously, they worked as a Territory Manager in oncology at Cepheid and contributed to their doctoral research on gene therapy technologies at Charité Berlin.
This person is not in the org chart
This person is not in any offices